Our study showed that exposure of NSCLC cells to low doses of ATM inhibitor induces a combined downregulation of glycolytic enzymes and OXPHOS with a significant reduction of glucose consumption and energy supply. Here, ATM is linked to non-small cell lung carcinoma.